{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:54:35Z","timestamp":1785884075782,"version":"3.56.0"},"reference-count":29,"publisher":"BMJ","issue":"10","funder":[{"name":"\u201cFund for Health Research of the Spanish Social Security Service\""}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,6,12]]},"published-print":{"date-parts":[[2018,10]]},"abstract":"\n Introduction<\/jats:title>\n The incidence of intrauterine growth restriction (IUGR) is estimated at about 3% of pregnancies, and it is associated with 30% of all perinatal mortality and severe morbidity with adverse neurodevelopmental and cardiovascular health consequences in adult life. Early onset IUGR represents 20%\u201330% of all cases and is highly associated with severe placental insufficiency. The existing evidence suggests that low molecular weight heparin (LMWH) has effects beyond its antithrombotic action, improving placental microvessel structure and function of pregnant women with vascular obstetric complications by normalising proangiogenic and antiapoptotic protein levels, cytokines and inflammatory factors. The objective of our study is to demonstrate the effectiveness of LMWH in prolonging gestation in pregnancies with early-onset IUGR.<\/jats:p>\n <\/jats:sec>\n \n Methods and analysis<\/jats:title>\n This is a multicentre, triple-blind, parallel-arm randomised clinical trial. Singleton pregnancies qualifying for early (20\u201332 weeks at diagnosis) placental IUGR (according to Delphi criteria) will be randomised to subcutaneous treatment with bemiparin 3500 IU\/0.2\u2009mL\/day or placebo from inclusion at diagnosis to the time of delivery. Analyses will be based on originally assigned groups (intention-to-treat). The primary objective will be analysed by comparing gestational age and prolongation of pregnancy (days) in each group with Student\u2019s t-tests for independent samples and by comparing Kaplan-Maier survival curves (from inclusion to delivery, log-rank test). A linear regression model for gestational age at birth will consider the following covariates: gestational age at inclusion (continuous) and pre-eclampsia (binary).<\/jats:p>\n <\/jats:sec>\n \n Ethics and dissemination<\/jats:title>\n \n The study will be conducted in accordance with the principles of Good Clinical Practice. This study was approved by the Clinical Research Ethics Committee (CEIC) of Sant Joan de D\u00e9u Hospital, on 13 July 2017. The trial is registered in the public registry\n www.clinicaltrial.gov<\/jats:ext-link>\n . according to Science Law 14\/2011, and the results will be published in an open access journal.\n <\/jats:p>\n <\/jats:sec>\n \n Trial registration number<\/jats:title>\n \n NCT03324139<\/jats:ext-link>\n ; Pre-results.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-020501","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T17:31:39Z","timestamp":1588872699000},"page":"e020501","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP)"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct03324139","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0069-7640","authenticated-orcid":false,"given":"Edurne","family":"Mazarico","sequence":"first","affiliation":[{"name":"BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Cl\u00ednic and Hospital Sant Joan de D\u00e9u), University of Barcelona, Barcelona, Spain"},{"name":"Institut de Recerca Sant Joan de D\u00e9u, Esplugues de Llobregat, Spain"},{"name":"Maternal and Child Health and Development Network II (SAMID II), funded by Instituto de Salud Carlos III (ISCIII), Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Peguero","sequence":"additional","affiliation":[{"name":"Fetal i+D Fetal Medicine Research Center, BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Cl\u00ednic and Hospital Sant Joan de D\u00e9u), University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Camprub\u00ed","sequence":"additional","affiliation":[{"name":"BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Cl\u00ednic and Hospital Sant Joan de D\u00e9u), University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Rovira","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Sant Joan de D\u00e9u, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Gomez Roig","sequence":"additional","affiliation":[{"name":"BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Cl\u00ednic and Hospital Sant Joan de D\u00e9u), University of Barcelona, Barcelona, Spain"},{"name":"Institut de Recerca Sant Joan de D\u00e9u, Esplugues de Llobregat, Spain"},{"name":"Maternal and Child Health and Development Network II (SAMID II), funded by Instituto de Salud Carlos III (ISCIII), Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Oros","sequence":"additional","affiliation":[{"name":"Maternal and Child Health and Development Network II (SAMID II), funded by Instituto de Salud Carlos III (ISCIII), Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), Barcelona, Spain"},{"name":"Aragon Institute for Health Research (IIS Arag\u00f3n), Obstetrics Department, Hospital Cl\u00ednico Universitario Zaragoza, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ib\u00e1\u00f1ez-Burillo","sequence":"additional","affiliation":[{"name":"Aragon Institute for Health Research (IIS Arag\u00f3n), Obstetrics Department, Hospital Cl\u00ednico Universitario Zaragoza, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Schoorlemmer","sequence":"additional","affiliation":[{"name":"Institute for Health Sciences in Aragon (IACS), Aragon Institute for Health Research (IIS Arag\u00f3n), Pluripotency in Embryonic Stem Cells group, Centro de Investigaci\u00f3n Biom\u00e9dica de Arag\u00f3n (CIBA), ARAID Foundation, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narc\u00eds","family":"Masoller","sequence":"additional","affiliation":[{"name":"Fetal i+D Fetal Medicine Research Center, BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Cl\u00ednic and Hospital Sant Joan de D\u00e9u), University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolors","family":"T\u00e0ssies","sequence":"additional","affiliation":[{"name":"Department of Hemotherapy Hemostasis, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Figueras","sequence":"additional","affiliation":[{"name":"Fetal i+D Fetal Medicine Research Center, BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Cl\u00ednic and Hospital Sant Joan de D\u00e9u), University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"2025121513580707000_8.10.e020501.1","doi-asserted-by":"publisher","DOI":"10.1159\/000357592"},{"key":"2025121513580707000_8.10.e020501.2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000253215.79121.75"},{"key":"2025121513580707000_8.10.e020501.3","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-2-53"},{"key":"2025121513580707000_8.10.e020501.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2007.05.002"},{"key":"2025121513580707000_8.10.e020501.5","doi-asserted-by":"publisher","DOI":"10.1046\/j.0960-7692.2001.00590.x"},{"key":"2025121513580707000_8.10.e020501.6","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.164533"},{"key":"2025121513580707000_8.10.e020501.7","doi-asserted-by":"crossref","unstructured":"Abheiden C , Van Hoorn ME , Hague WM , et al . Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results. BJOG 2016;123.doi:10.1111\/1471-0528.13421","DOI":"10.1111\/1471-0528.13689"},{"key":"2025121513580707000_8.10.e020501.8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.thromres.2015.11.026","article-title":"Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function","volume":"137","author":"Shomer","year":"2016","journal-title":"Thromb Res"},{"key":"2025121513580707000_8.10.e020501.9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01494"},{"key":"2025121513580707000_8.10.e020501.10","first-page":"359","article-title":"Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast","volume":"16","author":"Dunk","year":"2001","journal-title":"Histol Histopathol"},{"key":"2025121513580707000_8.10.e020501.11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3892\/etm.2015.2194","article-title":"Decreased expression of matrix metalloproteinase-1 in the maternal umbilical serum, trophoblasts and decidua leads to preeclampsia","volume":"9","author":"Deng","year":"2015","journal-title":"Exp Ther Med"},{"key":"2025121513580707000_8.10.e020501.12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000369363","article-title":"Tumor necrosis factor-\u03b1 and pregnancy complications: a prospective study","volume":"24","author":"Azizieh","year":"2015","journal-title":"Med Princ Pract"},{"key":"2025121513580707000_8.10.e020501.13","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.119176"},{"key":"2025121513580707000_8.10.e020501.14","first-page":"CD006780","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"24","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121513580707000_8.10.e020501.15","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15789"},{"key":"2025121513580707000_8.10.e020501.16","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"2025121513580707000_8.10.e020501.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04407.x"},{"key":"2025121513580707000_8.10.e020501.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2014.07.010"},{"key":"2025121513580707000_8.10.e020501.19","first-page":"793","article-title":"[Effect of heparin on fetal growth restriction]","volume":"39","author":"Yu","year":"2004","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2025121513580707000_8.10.e020501.20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3109\/14767050903443459","article-title":"Heparin for patients with growth restricted fetus: a prospective randomized controlled trial","volume":"23","author":"Yu","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025121513580707000_8.10.e020501.21","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15884"},{"key":"2025121513580707000_8.10.e020501.22","first-page":"97","article-title":"Editrial\/Pregnancy Hypertension","volume":"4","author":"Anon","year":"2014","journal-title":"Int J Women Cardio Healt"},{"key":"2025121513580707000_8.10.e020501.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2006.12.015"},{"key":"2025121513580707000_8.10.e020501.24","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5315"},{"key":"2025121513580707000_8.10.e020501.25","doi-asserted-by":"publisher","DOI":"10.1515\/jpme.1990.18.3.165"},{"key":"2025121513580707000_8.10.e020501.26","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20"},{"key":"2025121513580707000_8.10.e020501.27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1994.04050381.x"},{"key":"2025121513580707000_8.10.e020501.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1975.tb00710.x"},{"key":"2025121513580707000_8.10.e020501.29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-020501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T21:58:12Z","timestamp":1765835892000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-020501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,23]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1136\/bmjopen-2017-020501"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-020501","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}